Announced details
Aesthetic medicine, skin-care clinics, digital transformation of clinic operations, anti-aging care
More than 130,000 contracted cell-processing and related cases (cumulative)
A business relationship in which セルソース supports the introduction of systems as part of its management support for the first medical institution of FAST CLINIC, operated by its partner medical institution
Facility number for an authorized facility for the manufacture of specified cell-processed products and other materials: FA3240004 (expiry date: Not disclosed)
First medical institution: Futako-Tamagawa (detailed address: Not disclosed)
Reasonable price range (specific amount: Not disclosed)
The company does not address Contract Value / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | FAST CLINIC, Digital transformation systems for clinic operations, including reservation, electronic medical record and check-in systems |
| Relationship with the Company | A business relationship in which セルソース supports the introduction of systems as part of its management support for the first medical institution of FAST CLINIC, operated by its partner medical institution |
| Offering price | Reasonable price range (specific amount: Not disclosed) |
| Launch date | 1 June 2026 (already commenced) |
| Applicable area | Aesthetic medicine, skin-care clinics, digital transformation of clinic operations, anti-aging care |
| Registration number and expiry date | Facility number for an authorized facility for the manufacture of specified cell-processed products and other materials: FA3240004 (expiry date: Not disclosed) |
| Location | First medical institution: Futako-Tamagawa (detailed address: Not disclosed) |
| Usage history | More than 130,000 contracted cell-processing and related cases (cumulative) |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.As part of its expansion into the Wellness & Longevity field and the restructuring of its business portfolio, to address challenges in the conventional aesthetic medicine industry and realize “skin maintenance that is easy to continue.”